Reiko Namikawa
Director/Board Member at TMS CO., LTD.
Network origin in Reiko Namikawa first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Mitsui & Co. Global Investment, Inc.
 Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California.
19
| Subsidiary | Investment Managers | 19 |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.
12
| Holding Company | Pharmaceuticals: Major | 12 |
| Public Company | Miscellaneous Commercial Services | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Reiko Namikawa via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| MITSUI & CO., LTD. | Chemicals: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member | |
| Stanford University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
Intel Capital Corp.
 Intel Capital Corp. Investment ManagersFinance Intel Capital Corp (Intel Capital) is a venture capital subsidiary of Intel Corp founded in 1991 by Les Vadasz, and Avram Miller. The firm is headquartered in Wilmington, Delaware. | Investment Managers | Corporate Officer/Principal | |
| JAPAN ASIA INVESTMENT CO., LTD. | Investment Managers | Corporate Officer/Principal | |
| Keio University | College/University | Graduate Degree Undergraduate Degree | |
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Miscellaneous Commercial Services | Chief Operating Officer | |
| Osaka University | College/University | Graduate Degree Graduate Degree | |
| The University of Southampton | College/University | Doctorate Degree | |
| The California State University | College/University | Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin | |
| University of Madras | College/University | Undergraduate Degree | |
| Waseda University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Warwick | College/University | Masters Business Admin | |
| Kyushu University | College/University | Undergraduate Degree | |
| University of Tokyo | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Saitama University | College/University | Doctorate Degree Undergraduate Degree | |
| Nagoya University | College/University | Graduate Degree Graduate Degree | |
| Kyoto University | College/University | Graduate Degree Graduate Degree | |
| Tokyo Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
4INFO, Inc.
 4INFO, Inc. Packaged SoftwareTechnology Services 4INFO, Inc. engages in the provision of mobile display advertising technology. It offers retail, automotive, financial and CPG solutions. The company was founded by Michael Stachowiak, Markus A. Nordvik, Pankaj B. Shah, Zaw Thet, and David E. Siminoff in 2004 and is headquarters in San Mateo, CA. | Packaged Software | Director/Board Member | |
Mitsui & Co. (Asia Pacific) Pte Ltd.
 Mitsui & Co. (Asia Pacific) Pte Ltd. Financial ConglomeratesFinance Mitsui & Co. (Asia Pacific) Pte Ltd. provides financial services. Its service areas include iron and steel products, mineral and metal resources, infrastructure projects, integrated transportation systems, basic chemicals, performance chemicals, energy, foods and retail, consumer service, innovation and corporate development, and strategic development. The company was founded on April 1, 2007 and is headquartered in Singapore. | Financial Conglomerates | Corporate Officer/Principal | |
| SNBL Clinical Pharmacology Center, Inc. | Director/Board Member | ||
SNBL USA Ltd.
 SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Medical/Nursing Services | Director of Finance/CFO | |
| Japan Advanced Institute of Science & Technology | College/University | Graduate Degree | |
| Tokyo University of Agriculture & Technology | College/University | Corporate Officer/Principal | |
| RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Medipolis Medical Research Institute
 Medipolis Medical Research Institute Medical/Nursing ServicesHealth Services Medipolis Medical Research Institute offers proton beam cancer treatment. The company was founded on March 2006 and is headquartered in Ibusuki, Japan. | Medical/Nursing Services | Director/Board Member | |
| Suasa Kristal (M) Bhd. | Director/Board Member | ||
| Lexwell Partners | Founder | ||
PRISM BioLab Co., Ltd.
 PRISM BioLab Co., Ltd. BiotechnologyHealth Technology PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan. | Biotechnology | Director/Board Member | |
Miyako Capital KK
 Miyako Capital KK Investment ManagersFinance Miyako Capital KK (Miyako Capital) is an Independent Private Equity/Venture Capital firm founded in 2013 by Satoshi Yamaguchi and Hiroaki Okahashi. Miyako Capital KK is headquartered in Kyoto. | Investment Managers | Private Equity Investor | |
Okinawa Protein Tomography Ltd.
 Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Director/Board Member | |
Mitsubishi Corporation LT USA
 Mitsubishi Corporation LT USA Wholesale DistributorsDistribution Services Part of Mitsubishi Corp., Mitsubishi Corporation LT USA is a company that engages in the distribution of electronics, fuels, metals, and chemicals. The company is based in Schaumburg, IL. | Wholesale Distributors | Corporate Officer/Principal | |
Mitsui & Co. Asset Management Holdings Ltd.
 Mitsui & Co. Asset Management Holdings Ltd. Investment ManagersFinance Mitsui & Co. Asset Management Holdings Ltd. engages in the asset management business. It acts as a strategic base for real estate fund management companies establishment, as well as plans and implements merger and acquisition schemes. The company was founded on April 1, 2016 and is headquartered in Tokyo, Japan. | Investment Managers | Director/Board Member | |
| FUNPEP COMPANY LIMITED | Biotechnology | Founder | |
| SATSUMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
CellAxia, Inc.
 CellAxia, Inc. Pharmaceuticals: MajorHealth Technology CellAxia, Inc. is a Japanese company that engages in research and development, manufacturing, and selling of pharmaceutical products. The company is based in Tokyo, Japan. The company was founded in 2017 by Makoto Seki. | Pharmaceuticals: Major | Director/Board Member | |
PPD-SNBL KK
 PPD-SNBL KK Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., PPD-SNBL KK is a Japanese company that provides clinical research services. The company is based in Tokyo, Japan. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
ARTham Therapeutics, Inc.
 ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Pharmaceuticals: Major | Director/Board Member | |
| TICON FREEHOLD AND LEASEHOLD REAL ESTATE INVESTMENT TRUST | Real Estate Investment Trusts | Director/Board Member |
Statistics
International
| Japan | 26 |
| United States | 17 |
| Singapore | 3 |
| United Kingdom | 3 |
| Vietnam | 2 |
Sectoral
| Consumer Services | 19 |
| Health Technology | 9 |
| Finance | 8 |
| Health Services | 4 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 75 |
| Corporate Officer/Principal | 38 |
| Undergraduate Degree | 24 |
| Graduate Degree | 20 |
| Private Equity Investor | 15 |
Most connected contacts
- Stock Market
- Insiders
- Reiko Namikawa
- Company connections
